Review



primary antibodies against eyfp  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 98
      Buy from Supplier

    Structured Review

    Cell Signaling Technology Inc primary antibodies against eyfp
    A, Schematic of mouse models: two doses of tamoxifen (3 mg × 2) were injected intraperitoneally with a 48-hour interval. B, Representative immunofluorescence <t>(IF)</t> <t>staining</t> of <t>EYFP</t> in stomach tissues from Tmprss2-CreER T2 ;Rosa26-LSL-EYFP mice . Nuclei were counterstained with DAPI. Scale bar, 200 µm. C, Kaplan-Meier plots showing the survival of mice after gene knockout. D, Stomach weight of the indicated genetically engineered mouse model (GEMM) six weeks after tamoxifen injection. Data are presented as mean ± SD and analyzed with two-tailed t-test. E, Thickness in corpus mucosa measured by microscopy of hematoxylin and eosin (H&E) staining section. Each dot represents the averaged thickness of 5 random fields from one mouse. Data are presented as mean ± SD and analyzed with two-tailed t-test. F, Representative H&E staining of stomach tissues after tamoxifen administration. Scale bar, 200 µm. G, Pathological staging of stomach cancer progression based on infiltration of tumor cells in TPCD mice. H, Representative H&E staining of small and large intestines in TPCD mice. Scale bar, 1 mm.
    Primary Antibodies Against Eyfp, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 98/100, based on 1128 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against eyfp/product/Cell Signaling Technology Inc
    Average 98 stars, based on 1128 article reviews
    primary antibodies against eyfp - by Bioz Stars, 2026-03
    98/100 stars

    Images

    1) Product Images from "Loss of Kmt2c / d promotes gastric cancer initiation and confers vulnerability to mTORC1 inhibition and anti-PD1 immunotherapy"

    Article Title: Loss of Kmt2c / d promotes gastric cancer initiation and confers vulnerability to mTORC1 inhibition and anti-PD1 immunotherapy

    Journal: bioRxiv

    doi: 10.1101/2025.03.27.645747

    A, Schematic of mouse models: two doses of tamoxifen (3 mg × 2) were injected intraperitoneally with a 48-hour interval. B, Representative immunofluorescence (IF) staining of EYFP in stomach tissues from Tmprss2-CreER T2 ;Rosa26-LSL-EYFP mice . Nuclei were counterstained with DAPI. Scale bar, 200 µm. C, Kaplan-Meier plots showing the survival of mice after gene knockout. D, Stomach weight of the indicated genetically engineered mouse model (GEMM) six weeks after tamoxifen injection. Data are presented as mean ± SD and analyzed with two-tailed t-test. E, Thickness in corpus mucosa measured by microscopy of hematoxylin and eosin (H&E) staining section. Each dot represents the averaged thickness of 5 random fields from one mouse. Data are presented as mean ± SD and analyzed with two-tailed t-test. F, Representative H&E staining of stomach tissues after tamoxifen administration. Scale bar, 200 µm. G, Pathological staging of stomach cancer progression based on infiltration of tumor cells in TPCD mice. H, Representative H&E staining of small and large intestines in TPCD mice. Scale bar, 1 mm.
    Figure Legend Snippet: A, Schematic of mouse models: two doses of tamoxifen (3 mg × 2) were injected intraperitoneally with a 48-hour interval. B, Representative immunofluorescence (IF) staining of EYFP in stomach tissues from Tmprss2-CreER T2 ;Rosa26-LSL-EYFP mice . Nuclei were counterstained with DAPI. Scale bar, 200 µm. C, Kaplan-Meier plots showing the survival of mice after gene knockout. D, Stomach weight of the indicated genetically engineered mouse model (GEMM) six weeks after tamoxifen injection. Data are presented as mean ± SD and analyzed with two-tailed t-test. E, Thickness in corpus mucosa measured by microscopy of hematoxylin and eosin (H&E) staining section. Each dot represents the averaged thickness of 5 random fields from one mouse. Data are presented as mean ± SD and analyzed with two-tailed t-test. F, Representative H&E staining of stomach tissues after tamoxifen administration. Scale bar, 200 µm. G, Pathological staging of stomach cancer progression based on infiltration of tumor cells in TPCD mice. H, Representative H&E staining of small and large intestines in TPCD mice. Scale bar, 1 mm.

    Techniques Used: Injection, Immunofluorescence, Staining, Gene Knockout, Two Tailed Test, Microscopy



    Similar Products

    primary antibodies against eyfp  (Cell Signaling Technology Inc)
    98
    Cell Signaling Technology Inc primary antibodies against eyfp
    A, Schematic of mouse models: two doses of tamoxifen (3 mg × 2) were injected intraperitoneally with a 48-hour interval. B, Representative immunofluorescence <t>(IF)</t> <t>staining</t> of <t>EYFP</t> in stomach tissues from Tmprss2-CreER T2 ;Rosa26-LSL-EYFP mice . Nuclei were counterstained with DAPI. Scale bar, 200 µm. C, Kaplan-Meier plots showing the survival of mice after gene knockout. D, Stomach weight of the indicated genetically engineered mouse model (GEMM) six weeks after tamoxifen injection. Data are presented as mean ± SD and analyzed with two-tailed t-test. E, Thickness in corpus mucosa measured by microscopy of hematoxylin and eosin (H&E) staining section. Each dot represents the averaged thickness of 5 random fields from one mouse. Data are presented as mean ± SD and analyzed with two-tailed t-test. F, Representative H&E staining of stomach tissues after tamoxifen administration. Scale bar, 200 µm. G, Pathological staging of stomach cancer progression based on infiltration of tumor cells in TPCD mice. H, Representative H&E staining of small and large intestines in TPCD mice. Scale bar, 1 mm.
    Primary Antibodies Against Eyfp, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against eyfp/product/Cell Signaling Technology Inc
    Average 98 stars, based on 1 article reviews
    primary antibodies against eyfp - by Bioz Stars, 2026-03
    98/100 stars
    		  Buy from Supplier
    primary antibodies against (i) gfp/eyfp  (Thermo Fisher)
    90
    Thermo Fisher primary antibodies against (i) gfp/eyfp
    A, Schematic of mouse models: two doses of tamoxifen (3 mg × 2) were injected intraperitoneally with a 48-hour interval. B, Representative immunofluorescence <t>(IF)</t> <t>staining</t> of <t>EYFP</t> in stomach tissues from Tmprss2-CreER T2 ;Rosa26-LSL-EYFP mice . Nuclei were counterstained with DAPI. Scale bar, 200 µm. C, Kaplan-Meier plots showing the survival of mice after gene knockout. D, Stomach weight of the indicated genetically engineered mouse model (GEMM) six weeks after tamoxifen injection. Data are presented as mean ± SD and analyzed with two-tailed t-test. E, Thickness in corpus mucosa measured by microscopy of hematoxylin and eosin (H&E) staining section. Each dot represents the averaged thickness of 5 random fields from one mouse. Data are presented as mean ± SD and analyzed with two-tailed t-test. F, Representative H&E staining of stomach tissues after tamoxifen administration. Scale bar, 200 µm. G, Pathological staging of stomach cancer progression based on infiltration of tumor cells in TPCD mice. H, Representative H&E staining of small and large intestines in TPCD mice. Scale bar, 1 mm.
    Primary Antibodies Against (I) Gfp/Eyfp, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against (i) gfp/eyfp/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    primary antibodies against (i) gfp/eyfp - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    A, Schematic of mouse models: two doses of tamoxifen (3 mg × 2) were injected intraperitoneally with a 48-hour interval. B, Representative immunofluorescence (IF) staining of EYFP in stomach tissues from Tmprss2-CreER T2 ;Rosa26-LSL-EYFP mice . Nuclei were counterstained with DAPI. Scale bar, 200 µm. C, Kaplan-Meier plots showing the survival of mice after gene knockout. D, Stomach weight of the indicated genetically engineered mouse model (GEMM) six weeks after tamoxifen injection. Data are presented as mean ± SD and analyzed with two-tailed t-test. E, Thickness in corpus mucosa measured by microscopy of hematoxylin and eosin (H&E) staining section. Each dot represents the averaged thickness of 5 random fields from one mouse. Data are presented as mean ± SD and analyzed with two-tailed t-test. F, Representative H&E staining of stomach tissues after tamoxifen administration. Scale bar, 200 µm. G, Pathological staging of stomach cancer progression based on infiltration of tumor cells in TPCD mice. H, Representative H&E staining of small and large intestines in TPCD mice. Scale bar, 1 mm.

    Journal: bioRxiv

    Article Title: Loss of Kmt2c / d promotes gastric cancer initiation and confers vulnerability to mTORC1 inhibition and anti-PD1 immunotherapy

    doi: 10.1101/2025.03.27.645747

    Figure Lengend Snippet: A, Schematic of mouse models: two doses of tamoxifen (3 mg × 2) were injected intraperitoneally with a 48-hour interval. B, Representative immunofluorescence (IF) staining of EYFP in stomach tissues from Tmprss2-CreER T2 ;Rosa26-LSL-EYFP mice . Nuclei were counterstained with DAPI. Scale bar, 200 µm. C, Kaplan-Meier plots showing the survival of mice after gene knockout. D, Stomach weight of the indicated genetically engineered mouse model (GEMM) six weeks after tamoxifen injection. Data are presented as mean ± SD and analyzed with two-tailed t-test. E, Thickness in corpus mucosa measured by microscopy of hematoxylin and eosin (H&E) staining section. Each dot represents the averaged thickness of 5 random fields from one mouse. Data are presented as mean ± SD and analyzed with two-tailed t-test. F, Representative H&E staining of stomach tissues after tamoxifen administration. Scale bar, 200 µm. G, Pathological staging of stomach cancer progression based on infiltration of tumor cells in TPCD mice. H, Representative H&E staining of small and large intestines in TPCD mice. Scale bar, 1 mm.

    Article Snippet: Immunofluorescent staining was performed using primary antibodies against EYFP (2956, Cell Signaling Technology, 1:100), H3K4me1 (5326, Cell Signaling Technology, 1:100), ATP4A (D031-3, MBL Life Science, 1:500), and Puromycin (MABE343, Millipore Sigma, 1:100).

    Techniques: Injection, Immunofluorescence, Staining, Gene Knockout, Two Tailed Test, Microscopy